News|Articles|July 26, 2018
Contact Applied Clinical Trials Editors
Advertisement
Editorial Office
259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831
tel. 609-716-7777
Staff:
Davy James
Group Editorial Director
djames@mjhlifesciences.com
Editor
astudna@mjhlifesciences.com
Group Managing Editor
mchristel@mjhlifesciences.com
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
3
Measuring Whether Site Support Investments Are Actually Working
4
ACT Brief: AI-Enabled Workflow Automation, Subcutaneous Lunsumio VELO Approval, and Pan-KRAS Early-Stage Development
5